Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib for Bone Healing in Multiple Myeloma
NCT04028115Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM). Started Oct 2019; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04028115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028115.